A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing
2019
Edraki, Alireza | Mir, Aamir | Ibraheim, Raed | Gainetdinov, Ildar | Yoon, Yeonsoo | Song, Chun-Qing | Cao, Yueying | Gallant, Judith | Xue, Wen | Rivera-Pérez, Jaime A. | Sontheimer, Erik J.
CRISPR-Cas9 genome editing has transformed biotechnology and therapeutics. However, in vivo applications of some Cas9s are hindered by large size (limiting delivery by adeno-associated virus [AAV] vectors), off-target editing, or complex protospacer-adjacent motifs (PAMs) that restrict the density of recognition sequences in target DNA. Here, we exploited natural variation in the PAM-interacting domains (PIDs) of closely related Cas9s to identify a compact ortholog from Neisseria meningitidis—Nme2Cas9—that recognizes a simple dinucleotide PAM (N4CC) that provides for high target site density. All-in-one AAV delivery of Nme2Cas9 with a guide RNA targeting Pcsk9 in adult mouse liver produces efficient genome editing and reduced serum cholesterol with exceptionally high specificity. We further expand our single-AAV platform to pre-implanted zygotes for streamlined generation of genome-edited mice. Nme2Cas9 combines all-in-one AAV compatibility, exceptional editing accuracy within cells, and high target site density for in vivo genome editing applications.
显示更多 [+] 显示较少 [-]